Unknown

Dataset Information

0

The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer.

ABSTRACT:

SUBMITTER: Zamboglou C 

PROVIDER: S-EPMC5898009 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts.
| S-EPMC7136625 | biostudies-literature
Unknown 3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.
| S-EPMC3828667 | biostudies-literature
Unknown Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas.
| S-EPMC7527542 | biostudies-literature
Unknown Combination of <sup>68</sup>Ga-PSMA PET/CT and Multiparametric MRI Improves the Detection of Clinically Significant Prostate Cancer: A Lesion-by-Lesion Analysis.
| S-EPMC6604689 | biostudies-literature
Unknown Diagnostic Accuracy of <sup>68</sup>Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer.
| S-EPMC6283324 | biostudies-literature
Unknown Automatic segmentation and classification of breast lesions through identification of informative multiparametric PET/MRI features.
| S-EPMC6486931 | biostudies-literature
Unknown Effect of androgen deprivation therapy on intraprostatic tumour volume identified on 18F choline PET/CT for prostate dose painting radiotherapy.
| S-EPMC5601534 | biostudies-literature
Unknown Localization of primary prostate cancer: FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
| S-EPMC8569330 | biostudies-literature
Unknown Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer.
| S-EPMC6232089 | biostudies-literature
Unknown PSMA-targeted [18F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework.
| S-EPMC6348696 | biostudies-literature